Citius Pharmaceuticals (CTXR) Change in Inventory (2024 - 2026)
Citius Pharmaceuticals' (CTXR) quarterly Change in Inventory came in at $20248.0 in Q1 2026, down 97.89% YoY from $957884.0 in Q1 2025, and down 94.26% on a QoQ basis from $352649.0 in Q4 2025.
Citius Pharmaceuticals (CTXR) Change in Inventory (2024 - 2026) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 3 years of Change in Inventory data on file, last reported at $20248.0 in Q1 2026.
- Quarterly Change in Inventory fell 97.89% year-over-year to $20248.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (changed N/A YoY) and the FY2025 annual result came in at $12.6 million, up 492.78% from the prior year.
- Change in Inventory eased to $20248.0 in Q1 2026, from $352649.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $6.1 million in Q4 2024 to a low of $20248.0 in Q1 2026.
- A 3-year average of $2.2 million and a median of $1.4 million in 2025 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2025 — Change in Inventory plunged 94.23% — and 2026, when it plunged 97.89%.
- Tracing CTXR's Change in Inventory over 3 years: stood at $6.1 million in 2024, then tumbled by 94.23% to $352649.0 in 2025, then tumbled by 94.26% to $20248.0 in 2026.
- The last three Change in Inventory figures came in at $20248.0 (Q1 2026), $352649.0 (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - | - |
| 10 | Citius Pharmaceuticals | 15.86 Mn | 15.86 Mn | 1.00 Mn | -33,645.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,248.00 |
| Mar 31, 2026 | 20,248.00 |
| Dec 31, 2025 | 352,649.00 |
| Dec 31, 2025 | 352,649.00 |
| Sep 30, 2025 | 3.71 Mn |
| Sep 30, 2025 | 3.71 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 957,884.00 |
| Mar 31, 2025 | 957,884.00 |
| Dec 31, 2024 | 6.11 Mn |
| Dec 31, 2024 | 6.11 Mn |